IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Deep Track Capital, LP

Q1 2023 Holdings

Filed 2023-05-15 | 58 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Pliant Therapeutics Inc(PLRX)COM729139105$91.0M3,422,0573.7%
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$92.1M1,700,0003.8%
Ionis Pharmaceuticals Inc(IONS)COM462222100$101.3M2,834,0694.2%
Insmed Inc(INSM)COM PAR $.01457669307$110.8M6,500,0004.6%
Immunovant Inc(IMVT)COM45258J102$115.3M7,432,7174.7%
Travere Therapeutics Inc(TVTX)COM89422G107$138.3M6,147,2685.7%
Iveric BIO Inc(OPHTEUR)COM46583P102$158.1M6,500,0006.5%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$175.6M1,200,0007.2%
PreviousPage 2 of 2